Who Paid My Doc
Optune
Device Oncology
PDI 07290107982207
General payments
$1,456,931
Research payments
$1,015,460
Through program year 2023, $1,456,931 in general payments and $1,015,460 in research payments were reported against Optune (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $497,465 | 2,546 |
| 2022 | General | $515,625 | 2,398 |
| 2021 | General | $443,841 | 2,263 |
| 2021 | Research | $1,015,460 | 95 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 56 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
7,207 general · 95 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.